 |
The fabric of the in vitro diagnostics (IVD) industry is changing. New names are appearing at the top and some emerging specialists are being valued more than some traditional big names: Siemens and Inverness entered the ranks of the top ten by sales after a flurry of deals in 2006-2007, and the women’s healthcare specialist, Hologic, increased its value through key combinations in 2007-2008.
In this new report, PricewaterhouseCoopers reviews deal activity in the in vitro diagnostics (IVD) sector and significant events for personalised medicine, a field which is fast rising to prominence in healthcare innovation.
The report covers: M&A and licensing deal activity; Biomarkers and companion diagnostics; Partnerships with the pharmaceutical industry; Significant events for personalised medicine; Case studies; Drivers of future revenue growth for personalised medicine.
|
Email to a colleague
Print-friendly version